From early drug testing to toxicity assessment and safety profiling,
we empower you to make informed decisions about the safety and efficacy of compounds.
Our organoids are created from human induced pluripotent stem cells (hiPSCs). When cultured under specific conditions, these hiPSCs transform into self-organizing complex structures that resemble the architecture and functionality of the human brain. This includes the presence of neurons, astrocytes, and, if desired, microglia. Our innovative technology of producing cortical organoids on a very large scale is patent-pending and forms the core of BrainZell's technology.
Our streamlined process ensures a seamless experience from project initiation to the delivery of valuable insights. We will define the study milestones, deliverables, and timelines.